Healthcare costs and nonadherence among chronic opioid users

American Journal of Managed Care

Volumn 17, Issue 1, 2011, Pages 32-40

  Leider, Harry L ^a   Dhaliwal, Jatinder ^a   Davis, Elizabeth J ^b   Kulakodlu, Mahesh ^b   Buikema, Ami R ^b  

^a Ameritox Ltd   (United States)

^b i3 Innovus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCODONE; ILLICIT DRUG; OPIATE; OXYCODONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC PAIN; CONTROLLED STUDY; DEMOGRAPHY; DRUG COST; DRUG MONITORING; DRUG URINE LEVEL; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; URINALYSIS;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ANALGESICS, OPIOID; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE CLAIM REVIEW; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OPIOID-RELATED DISORDERS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 79951848596     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. National Pharmaceutical Council, Joint Commission on Accreditation of Healthcare Organizations. Pain: Current Understanding of Assessment, Management, and Treatments. December 2001. http://d.scribd. com/docs/1qeor4k1bd6nmb8g71hj. pdf. Accessed October 6, 2009.
2. National Center for Health Statistics. Health, United States, 2006 With Chartbook on Trends in the Health of Americans. 2006. http:// www.cdc.gov/nchs/data/hus/hus06.pdf. Accessed October 20, 2009.
3. Becker N, Bondegaard TA, Olsen AK, Sjogren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 1997;73(3):393-400. (Pubitemid 28021844)
4. Cicero TJ, Wong G, Tian Y, Lynskey M, Todorov A, Isenberg K. Comorbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. Pain. 2009;144(1-2):20-27.
5. Federation of State Medical Boards of the United States Inc. Model Policy for the Use of Controlled Substances for the Treatment of Pain. May 2004. http://www.fsmb.org/pdf/2004-grpol-Controlled-Substances.pdf. Accessed October 6, 2009.
6. Savage S, Covington EC, Gilson AM, Gourlay D, Heit HA, Hunt JB. Public policy statement on the rights and responsibilities of healthcare professionals in the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. 2004. http://www.ampainsoc.org/advocacy/rights. htm. Accessed October 6, 2009.
7. Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
8. Savage SR. Management of opioid medications in patients with chronic pain and risk of substance misuse. Curr Psychiatry Rep. 2009;11(5):377-384.
9. Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008; 11(2suppl):S5-S62. (Pubitemid 351682078)
10. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107-112. (Pubitemid 40590522)
11. Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999;18(1):27-37. (Pubitemid 29344633)
12. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The TEDS Report: substance abuse treatment admissions involving abuse of pain relievers: 1998 and 2008. July 2010. http://oas.samhsa.gov/2k10/ 230/230PainRelvr2k10.htm. Accessed July 28, 2010.
13. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results From the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36, HHS publication SMA 09-4434. 2009. http://www.oas.samhsa.gov/ nsduh/2k8nsduh/2k8results.cfm#Ch2. Accessed August 12, 2010.
14. Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38(5):517-524.
15. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9(4):444-459. (Pubitemid 351722518)
16. Michna E, Jamison RN, Pham LD, et al. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predict- ability of abnormal findings. Clin J Pain. 2007;23(2):173-179. (Pubitemid 46145464)
17. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.
18. Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097-1102. (Pubitemid 37158696)
19. Cone EJ, Caplan YH. Urine toxicology testing in chronic pain management. Postgrad Med. 2009;121(4):91-102.
20. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006;9(1):57-60.
21. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. (Pubitemid 41587600)
22. 104th Congress of the United States. Health Insurance Portability and Accountability Act of 1996. Public Law 104-191. 1996. http://www. cms.hhs.gov/HIPAAGenlnfo/Downloads/HIPAALaw.pdf. Accessed January 12, 2010.
23. Couto JE, Romney MC, Leider HL, Sharma S, Goldfarb NI. High rates of inappropriate drug use in the chronic pain population. Popul Health Manag. 2009;12(4):185-190.
24. Couto JE, Webster L, Romney MC, Leider HL, Linden A. Use of an algorithm applied to urine drug screening to assess adherence to an oxycontin regimen [published correction appears in J Opioid Manag. 2010;6(3):167]. J Opioid Manag. 2009;5(6):359-364.
25. Kell MJ. Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients, II: generation of plasma concentration response curves. J Addict Dis. 1995;14(1):85-108.
26. Kell MJ. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics, I: measurement techniques for a clinical setting. J Addict Dis. 1994;13(1):5-26. (Pubitemid 24122147)
27. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
29. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. Chained consumer price index for all urban consumers (C-CPI-U) 1999-2008, Medical Care. Series ID: SUUR0000SAM. 2008. http://data.bls.gov/cgi-bin/ surveymost7su. Accessed March 17, 2010.
30. Blough DK, Madden CW, Hombrook MC. Modeling risk using generalized linear models. J Health Econ. 1999;18(2):153-171. (Pubitemid 29052479)
31. Marcus DA. Pharmacoeconomics of opioid therapy for chronic non-malignant pain. Expert Opin Pharmacother. 2002;3(3):229-235. (Pubitemid 34211110)
32. Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-290.
33. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chemew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010;48(5):409-417.
34. Lewis ET, Combs A, Trafton JA. Reasons for under-use of prescribed opioid medications by patients in pain. Pain Med. 2010;11(6):861-871.
35. Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15(7):556-562.
36. Harris KM, Edlund MJ. Self-medication of mental health problems: new evidence from a national survey. Health Serv Res. 2005;40(1): 117-134. (Pubitemid 40229352)
37. Siegal HA, Draus PJ, Carlson RG, Falck RS, Wang J. Perspectives on health among adult users of illicit stimulant drugs in rural Ohio. J Rural Health. 2006;22(2):169-173.
38. Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26(4):552-561. (Pubitemid 38586456)
39. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure [published correction appears in Pain. 2009;142(1-2):169]. Pain. 2007;130(1-2):144-156. (Pubitemid 46843461)